Gene · 7480
Papers1,778
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,778
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico analyses of Wnt1 nsSNPs reveal structurally destabilizing variants, altered interactions with Frizzled receptors and its deregulation in tumorigenesis. | Sci Rep | 2022 | 36056132 | PubTator, text mining | PubMed |
| Developmental genomics of limb malformations: Allelic series in association with gene dosage effects contribute to the clinical variability. | HGG Adv | 2022 | 36035248 | PubTator, text mining | PubMed |
| Mutation analysis in patients with nonsyndromic tooth agenesis using exome sequencing. | Mol Genet Genomic Med | 2022 | 36017684 | PubTator, text mining | PubMed |
| Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease. | Pharmaceuticals (Basel) | 2022 | 36015101 | PubTator, text mining | PubMed |
| The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer. | Int J Mol Sci | 2022 | 36012588 | PubTator, text mining | PubMed |
| Exosomes in Breast Cancer: Involvement in Tumor Dissemination and Prospects for Liquid Biopsy. | Int J Mol Sci | 2022 | 36012109 | PubTator, text mining | PubMed |
| MicroRNA-148a-3p is a candidate mediator of increased bone marrow adiposity and bone loss following spinal cord injury. | Front Endocrinol (Lausanne) | 2022 | 35992108 | PubTator, text mining | PubMed |
| Editorial: Immunotherapy in renal cell carcinoma. | Front Oncol | 2022 | 35965584 | PubTator, text mining | PubMed |
| The effect of maltobionic acid on bone metabolism markers in healthy Japanese postmenopausal women: A randomized double-blind placebo-controlled crossover study. | Food Sci Nutr | 2022 | 35959256 | PubTator, text mining | PubMed |
| Dysregulation of Subcutaneous White Adipose Tissue Inflammatory Environment Modelling in Non-Insulin Resistant Obesity and Responses to Omega-3 Fatty Acids - A Double Blind, Randomised Clinical Trial. | Front Immunol | 2022 | 35958557 | PubTator, text mining | PubMed |
| Design of functional biomaterials as substrates for corneal endothelium tissue engineering. | Regen Biomater | 2022 | 35958516 | PubTator, text mining | PubMed |
| Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer. | Front Oncol | 2022 | 35957916 | PubTator, text mining | PubMed |
| Mechanisms of Systemic Osteoporosis in Rheumatoid Arthritis. | Int J Mol Sci | 2022 | 35955873 | PubTator, text mining | PubMed |
| Adipose tissue in bone regeneration - stem cell source and beyond. | World J Stem Cells | 2022 | 35949397 | PubTator, text mining | PubMed |
| Comprehensive analysis of full-length transcripts reveals novel splicing abnormalities and oncogenic transcripts in liver cancer. | PLoS Genet | 2022 | 35926060 | PubTator, text mining | PubMed |
| Focusing on OB-OC-MΦ Axis and miR-23a to Explore the Pathogenesis and Treatment Strategy of Osteoporosis. | Front Endocrinol (Lausanne) | 2022 | 35909545 | PubTator, text mining | PubMed |
| Microduplication of BTRC detected in a Chinese family with split hand/foot malformation type 3. | Clin Genet | 2022 | 35908152 | PubTator, text mining | PubMed |
| Proof-of-Concept Organ-on-Chip Study: Topical Cinnamaldehyde Exposure of Reconstructed Human Skin with Integrated Neopapillae Cultured under Dynamic Flow. | Pharmaceutics | 2022 | 35893784 | PubTator, text mining | PubMed |
| Stem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential. | Stem Cell Res Ther | 2022 | 35883127 | PubTator, text mining | PubMed |
| Cyclic Adenosine Monophosphate (cAMP)-Dependent Phosphodiesterase Inhibition Promotes Bone Anabolism Through CD8+ T Cell Wnt-10b Production in Mice. | JBMR Plus | 2022 | 35866149 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7480/papers?page=20